Combs Andrew 4
4 · Prelude Therapeutics Inc · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Combs Andrew
Chief Chemistry Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-03-01+150,000→ 150,000 totalExercise: $4.59Exp: 2034-02-28→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on March 1, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.